Widespread availability of telemedicine during the pandemic led to more equitable access to endocrinology care for patients with type 2 diabetes and heart disease, according to a study being presented Monday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.
EC approves Novartis’ Kisqali for early breast cancer treatment
Novartis developed the therapy under a research partnership with Astex Pharmaceuticals. Credit: © 2024 Novartis AG. The European Commission (EC) has granted approval to Novartis‘